ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

ADVFN

Trade Now

EasyMarkets
Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P 500
4,585.59
(
0.8%
)
US Tech 100
15,617.20
(
0.0%
)
Dow Jones
36,117.38
(
0.17%
)
Brent Oil
75.795
(
1.55%
)
Bitcoin
43,237.04
(
-0.14%
)
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Anavex Life Sciences Corporation (AVXL)

  7. Anavex Life Sciences Corporation (AVXL) News

AVXL Anavex Life Sciences Corporation

8.13
0.00 (0.0%)
Dec 07 2023 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Anavex Life Sciences Corporation AVXL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
0.00 0.0% 8.13 19:00:00
Open Price Low Price High Price Close Price Prev Close
8.13
more quote information »

Recent News

Date Time Source Heading
11/27/202316:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11/27/202308:00GLOBEAnavex Life Sciences Reports Fiscal 2023 Year End Financial..
11/27/202306:29IHMARKETNEWSMonday’s Wall Street Highlights: Walmart, Disney, Lloyds..
11/24/202308:00GLOBEAnavex Life Sciences to Announce Fiscal 2023 Year End..
11/22/202308:00GLOBEAnavex Life Sciences Announces Grant of U.S. Patent Covering..
11/20/202308:00GLOBEAnavex Initiates Regulatory Submission of Oral Blarcamesine..
11/06/202308:00GLOBEAnavex Life Sciences Appoints Senior VP of Regulatory..
10/25/202308:00GLOBEAnavex Life Sciences Reports New Publication in Scientific..
9/14/202307:30GLOBEAnavex’s Phase 2b/3 Trial of Blarcamesine (ANAVEX®2-73) in..
9/12/202307:30GLOBEAnavex Announces Appointment of Dr. Marwan N Sabbagh, MD as..
8/08/202316:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202307:30GLOBEAnavex Life Sciences Reports Fiscal 2023 Third Quarter..
8/07/202307:30GLOBEAnavex Life Sciences Reports Publication of ANAVEX®3-71 in..
8/02/202307:30GLOBEAnavex Life Sciences to Present at the BTIG Virtual..
8/01/202307:30GLOBEAnavex Life Sciences to Announce Fiscal 2023 Third Quarter..
6/28/202307:30GLOBELong-term Clinical Study Demonstrates Disease Modifying..
6/27/202307:30GLOBEAnavex Life Sciences and Partex Group Announce Strategic..
6/20/202307:30GLOBEAnavex Life Sciences to Present at the H.C. Wainwright 4th..
6/15/202307:30GLOBEANAVEX®2-73 (blarcamesine) Receives Compassionate Use..
6/12/202307:30GLOBEAnavex Life Sciences Reports Publication in Medical Journal..
6/06/202307:30GLOBEAnavex Life Sciences Announces Completion of ANAVEX(®)2-73..
6/01/202307:30GLOBEANAVEX Announces Issuance of New U.S. Intellectual Property..
5/09/202307:30GLOBEAnavex Life Sciences Reports Fiscal 2023 Second Quarter..
5/02/202307:30GLOBEAnavex Life Sciences to Announce Fiscal 2023 Second Quarter..
5/01/202307:30GLOBEAnavex Life Sciences Announces Issuance of New U.S. Patent..
4/25/202307:30GLOBEAnavex Life Sciences to Present at the H.C. Wainwright..
4/10/202307:00GLOBEAnavex Life Sciences to Present at the 22nd Annual Needham..
3/30/202307:00GLOBEANAVEX®2-73 (Blarcamesine) Shows Clinical Benefit in..
3/13/202307:35IHNWNightfood, Inc. (OTCQB: NGTF) now in Sonesta International..
3/09/202307:00GLOBEAnavex Life Sciences Appoints Former FDA Lead Neurology..
2/07/202307:00GLOBEAnavex Life Sciences Reports Fiscal 2023 First Quarter..
2/02/202307:00GLOBEAnavex Life Sciences Announces Exceeding of Enrollment..
1/31/202307:00GLOBEAnavex Life Sciences to Announce Fiscal 2023 First Quarter..
12/14/202207:00GLOBEAnavex Strengthens Scientific Advisory Board with..
12/12/202207:00GLOBEAnavex Life Sciences to Present at the 41st Annual J.P...

Your Recent History

NASDAQ
AVXL
Anavex Life Sciences
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com